FINWIRES · TerminalLIVE
FINWIRES

United Therapeutics Insider Sold Shares Worth $4,671,399, According to a Recent SEC Filing

By

Paul A Mahon, Executive Vice President & General Counsel, on May 21, 2026, sold 8,300 shares in United Therapeutics (UTHR) for $4,671,399. Following the Form 4 filing with the SEC, Mahon has control over a total of 45,172 common shares of the company, with 45,172 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1082554/000123158926000012/xslF345X05/primarydocument.xml

Related Articles